EBEmily Boxer

Emily Boxer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emily Boxer has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Alissa R. Greenwald

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

    1 shared publication
  • Daniel Kovarsky

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

    1 shared publication
  • Dor Simkin

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

    1 shared publication
  • Itay Tirosh

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

    1 shared publication
  • Lingling Zhang

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

    1 shared publication
  • Nisan Feigin

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

    1 shared publication

Latest Publications

  • Top Cited Papers

    Emerging clinical applications of single-cell RNA sequencing in oncology

    by Emily Boxer, Nisan Feigin, Roi Tschernichovsky, Noam Galili Darnell, Alissa R. Greenwald, Rouven Hoefflin, Daniel Kovarsky, Dor Simkin, Shira Turgeman, Lingling Zhang, et al.

    Single-cell RNA sequencing (scRNA-seq) has revolutionized our understanding of complex tissues both in health and in disease. Over the past decade, scRNA-seq has been applied to tumour samples obtained from patients with cancer in hundreds of studies, thereby advancing the view that each tumour is a complex ecosystem and uncovering the diverse states of both cancer cells and the tumour microenvironment. Such studies have primarily investigated and provided insights into the basic biology of cancer, although considerable research interest exists in leveraging these findings towards clinical applications. In this Review, we summarize the available data from scRNA-seq studies investigating samples from patients with cancer with a particular focus on findings that are of potential clinical relevance. We highlight four main research objectives of scRNA-seq studies and describe some of the most relevant findings towards such goals. We also describe the limitations of scRNA-seq, as well as future approaches in this field that are anticipated to further advance clinical applicability.